Views: 0 Author: Site Editor Publish Time: 2025-07-02 Origin: Site
Since its debut in 1995, Intense Pulsed Light (IPL) photofacial has remained a gold-standard aesthetic treatment worldwide. Unlike fleeting trends, its versatility, safety, and proven results make it a top choice for addressing:
✔ Pigmentation (sun spots, melasma)
✔ Redness (rosacea, broken capillaries)
✔ Acne & scars
✔ Anti-aging (collagen stimulation)
✔ Hair reduction
IPL delivers broad-spectrum light (400–1200 nm) to target:
Melanin (breaks up dark spots)
Hemoglobin (reduces redness)
Water (tightens pores via mild heating)
Key Mechanism: Selective photothermolysis destroys problem areas while sparing healthy tissue.
Era | Milestone |
---|---|
1980s | Low-energy lasers for vein treatment (no cosmetic benefit) |
1990s | LED-based devices (red/blue light) for collagen stimulation |
2000s | IPL emerges with multi-wavelength capabilities |
2010s | Q-switched Nd:YAG lasers for deeper skin remodeling |
Present | Advanced IPL systems (OPT, AOPT, DPL, BBL) with customizable filters |
Upstream: Produces core components (laser diodes, LEDs).
Midstream: Assembles medical-grade devices.
Downstream: Clinics, spas, and at-home devices.
Market Growth (China):
2017: ¥5.8B → 2022: ¥15.2B (26% CAGR)
Driven by rising beauty demand, tech advancements, and stricter regulations.
OPT/AOPT: Most clinically established in China.
DPL/APT: Narrow-band precision for vascular/pigment issues.
BBL: Newer broadband technology with faster results.
2020 Medical Device Regulations: Replaced filing with mandatory NMPA certification.
GMP compliance required for manufacturers.
Stricter safety/efficacy standards to protect consumers.
Future Outlook:
With tech innovation (e.g., AI-powered customization) and growing demand for non-invasive treatments, the IPL market is poised for sustained growth.